Search research articles
Contact Us
Filters
Showing results (41-50 of 186) with videos related to
Page
of 19
Sort By:
The Laryngoscope
|
June 3, 2024
Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure
Sharon Tzelnick, John R de Almeida, Christopher M K L Yao, et al.
Cancers
|
July 29, 2023
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy
Maysa Vilbert, Erica C Koch, April A N Rose, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2011
Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors
Chiara Lazzari, Anna Spreafico, Angela Bachi, et al.
JCO Precision Oncology
|
April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.
F1000Research
|
December 10, 2020
Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
Milena Music, Marco Iafolla, Antoninus Soosaipillai, et al.
Molecular Oncology
|
April 24, 2012
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
John J Arcaroli, Rebecca W Powell, Marileila Varella-Garcia, et al.
Investigational New Drugs
|
April 12, 2018
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
Kyaw L Aung, Anthony B El-Khoueiry, Karen Gelmon, et al.
Clinical Colorectal Cancer
|
August 21, 2021
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
Kanan Alshammari, Kyaw L Aung, Tong Zhang, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 186) with videos related to
Sort By:
Page
of 19
The Laryngoscope
|
June 3, 2024
Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure
Sharon Tzelnick, John R de Almeida, Christopher M K L Yao, et al.
Cancers
|
July 29, 2023
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy
Maysa Vilbert, Erica C Koch, April A N Rose, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2011
Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors
Chiara Lazzari, Anna Spreafico, Angela Bachi, et al.
JCO Precision Oncology
|
April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.
F1000Research
|
December 10, 2020
Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
Milena Music, Marco Iafolla, Antoninus Soosaipillai, et al.
Molecular Oncology
|
April 24, 2012
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
John J Arcaroli, Rebecca W Powell, Marileila Varella-Garcia, et al.
Investigational New Drugs
|
April 12, 2018
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
Kyaw L Aung, Anthony B El-Khoueiry, Karen Gelmon, et al.
Clinical Colorectal Cancer
|
August 21, 2021
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
Kanan Alshammari, Kyaw L Aung, Tong Zhang, et al.
Page
of 19